Contract Research Organizations

Fewer Dropouts. Less Sponsor Escalation. Stronger RFP Positioning.

Every dropout triggers a chain your team absorbs - missed visits, protocol deviations, timeline extensions, sponsor escalation.
Canvs surfaces engagement risk before the chain starts.

Talk to Our Clinical Team

Trusted by Organizations That Understand Patient Experience

25.9%

CNS trial dropout rate -
highest of any therapeutic area

$40K/day

direct cost of Phase 2/3 trial delay

$30K-$70K

to replace a single dropped Phase 2 patient

How CROs Win with Canvs

Earlier warning, cleaner trials

Canvs flags engagement risk by site and cohort before it becomes a missed visit or protocol deviation - giving your team time to act.

Differentiate in sponsor RFPs

Sponsors are asking how CROs manage engagement risk. Canvs gives you a concrete, defensible answer your competitors don’t have.

Zero workflow disruption

Read-only. No new data collection. No protocol changes. Nothing that touches your regulatory posture or existing platforms.

Run cleaner trials.
Fewer surprises.

Patient disengagement starts in language - weeks before it shows up in your operational data. Canvs reads what’s behind the score, across every site and cohort, and tells you where engagement is shifting before your sponsor escalates.

Detect site-level disengagement before it compounds

Surface early warning by cohort, dose arm, and site

Reduce protocol deviations tied to patient disengagement

Every finding traceable to source verbatim

Talk to Our Clinical Team

Qualify stronger, more adherent patients at intake.

Up to 50% of research sites enroll one or no patients. The pressure to get intake right starts before the trial does. Canvs flags candidates whose language patterns predict dropout - before enrollment, not after.

No new intake process required

Flag high-risk candidates before they become statistics

Works at site networks of any size

Book a Meeting